On November 26, 2025, the Hong Kong stock market opened with gains across major indices. The Hang Seng Index rose 0.59%, the National Enterprise Index increased by 0.64%, the Hang Seng Technology Index climbed 0.67%, and the Red Chip Index edged up 0.21%.

Meituan up 4%; Ganfeng Lithium up 3%; Tianqi Lithium, BYD Company, XPeng up over 2%; Alibaba down over 2%; NIO down 7%.

Alibaba Group's stock fell 2.41% despite announcing plans to actively invest in enhancing its artificial intelligence capabilities, potentially exceeding the previously committed RMB 380 billion investment over three years due to strong customer demand. The company also highlighted potential supply chain issues in server construction due to rapid growth in AI and cloud services.

BYD Company saw a rise of 2.30% as Tongda Power disclosed its long-term cooperation with major clients including BYD in the motor iron core supporting business.

Hengrui Pharma's stock increased by 1.63% following the approval from the National Medical Products Administration for clinical trials of two innovative anti-tumor drugs, HRS-8364 tablets and injectable Ruikang Trastuzumab.

NIO's stock dropped 6.96% after releasing its third-quarter financial report, which showed record revenue and a narrowed net loss. The company expressed confidence in achieving profitability in the fourth quarter of 2025, driven by high-margin models and strong orders.